IL262544A - A method for producing a recombinant protein - Google Patents

A method for producing a recombinant protein

Info

Publication number
IL262544A
IL262544A IL262544A IL26254418A IL262544A IL 262544 A IL262544 A IL 262544A IL 262544 A IL262544 A IL 262544A IL 26254418 A IL26254418 A IL 26254418A IL 262544 A IL262544 A IL 262544A
Authority
IL
Israel
Prior art keywords
producing
recombinant protein
recombinant
protein
Prior art date
Application number
IL262544A
Other languages
English (en)
Hebrew (he)
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of IL262544A publication Critical patent/IL262544A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL262544A 2016-05-06 2018-10-24 A method for producing a recombinant protein IL262544A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662332636P 2016-05-06 2016-05-06
US201662338045P 2016-05-18 2016-05-18
PCT/EP2017/060654 WO2017191255A1 (en) 2016-05-06 2017-05-04 Method of producing a recombinant protein

Publications (1)

Publication Number Publication Date
IL262544A true IL262544A (en) 2018-12-31

Family

ID=58765814

Family Applications (1)

Application Number Title Priority Date Filing Date
IL262544A IL262544A (en) 2016-05-06 2018-10-24 A method for producing a recombinant protein

Country Status (14)

Country Link
US (1) US11098312B2 (cg-RX-API-DMAC10.html)
EP (1) EP3452496A1 (cg-RX-API-DMAC10.html)
JP (2) JP2019516371A (cg-RX-API-DMAC10.html)
KR (1) KR102504317B1 (cg-RX-API-DMAC10.html)
CN (1) CN109071611B (cg-RX-API-DMAC10.html)
AU (1) AU2017260277A1 (cg-RX-API-DMAC10.html)
BR (1) BR112018072043A2 (cg-RX-API-DMAC10.html)
CA (1) CA3023025A1 (cg-RX-API-DMAC10.html)
IL (1) IL262544A (cg-RX-API-DMAC10.html)
MX (1) MX2018013562A (cg-RX-API-DMAC10.html)
RU (1) RU2742006C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201808976WA (cg-RX-API-DMAC10.html)
TW (1) TWI794170B (cg-RX-API-DMAC10.html)
WO (1) WO2017191255A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020165874A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited A bacterial expression vector for enhanced protein secretion
KR102094480B1 (ko) 2019-05-27 2020-04-01 (주)엘에스케이화인텍스 재사용 가능한 미세 먼지 항균 마스크
CN110551199B (zh) * 2019-09-26 2022-01-25 杭州纽龙日尚生物制品有限公司 一种提高工程菌分泌表达重组人表皮生长因子的方法
KR20240021234A (ko) 2021-06-10 2024-02-16 펠리칸 테크놀로지 홀딩스, 인크. 재조합 단백질 발현을 위한 박테리아 숙주

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546342A2 (en) * 2002-09-20 2005-06-29 Cym1P A/S Methods for increasing the production of a recombinant polypeptide from a host cell
GB0426160D0 (en) * 2004-11-29 2004-12-29 Era Plantech S L Production of proteins
KR100981356B1 (ko) * 2006-01-31 2010-09-14 대한민국 신호서열 및 변이된 신호서열로 디자인된 분비증강자에의한 원래 형태의 수용성 재조합 단백질 생산 방법
GB0602173D0 (en) 2006-02-03 2006-03-15 Avecia Ltd Expression system
WO2009021548A1 (en) * 2007-08-10 2009-02-19 Wacker Chemie Ag Expression of full length igg and secretion into the culture medium of prokaryotic cells
RU2488635C1 (ru) * 2012-03-22 2013-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития Способ получения рекомбинантного антиангиогенного полипептида
US20140244228A1 (en) * 2012-09-19 2014-08-28 Agency For Science, Technology And Research Codon optimization of a synthetic gene(s) for protein expression

Also Published As

Publication number Publication date
US20190177734A1 (en) 2019-06-13
JP2019516371A (ja) 2019-06-20
SG11201808976WA (en) 2018-11-29
AU2017260277A1 (en) 2018-11-22
KR102504317B1 (ko) 2023-02-24
RU2742006C2 (ru) 2021-02-01
KR20190003694A (ko) 2019-01-09
BR112018072043A2 (pt) 2019-02-12
CN109071611B (zh) 2022-11-01
RU2018137305A (ru) 2020-06-08
US11098312B2 (en) 2021-08-24
CA3023025A1 (en) 2017-11-09
WO2017191255A1 (en) 2017-11-09
TW201805298A (zh) 2018-02-16
TWI794170B (zh) 2023-03-01
JP2022070902A (ja) 2022-05-13
MX2018013562A (es) 2019-03-14
RU2018137305A3 (cg-RX-API-DMAC10.html) 2020-06-08
CN109071611A (zh) 2018-12-21
EP3452496A1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
IL249955A0 (en) A method for the computational design of proteins
GB201518792D0 (en) Production of proteins
ZA201900661B (en) Production method for insoluble recombinant protein aggregate
HUP1400114A2 (en) Method for the production of peptides
EP3153581A4 (en) Method for producing recombinant proteins using recombinant brevibacillus
IL279782B2 (en) Methods for producing recombinant proteins
GB201609235D0 (en) Production of a horseradish peroxidase-IGG fusion protein
IL253694A0 (en) A method for producing gonadotropin
EP3434782A4 (en) PROCESS FOR PRODUCING PROTEINS
GB201600512D0 (en) Recombinant protein production
IL258981A (en) Methods for the production of proteins
IL258982A (en) Method for producing a recombinant protein
IL252712A0 (en) Method for protein production
GB201609170D0 (en) Method of manufacture
SG11201708751RA (en) Method of producing a recombinant protein
SG11201605775UA (en) Method of producing a recombinant microorganism
HUE050105T2 (hu) Eljárás terápiás protein gyártására
PL3383615T3 (pl) Sposób formowania części
GB201613971D0 (en) Method of manufacture
GB201609171D0 (en) Method of manufacture
IL256706B (en) A method for making recombinant proteins
IL256707B (en) A method for the production of recombinant proteins
IL265297A (en) Methods for regulating production profiles of recombinant proteins
GB2544228B (en) Production Method of Joint Material
IL251740B (en) A method of producing vials of recombinant protein